UNSPSC 51144011: Fenfluramine hydrochloride

This classification denotes an anorexiant with the molecular formula C12H16F3N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3KC089243P, chemically known as phenethylamine, n-ethyl-alpha-methyl-m-(trifluoromethyl)-, (s)- but more generally known as fenfluramine hydrochloride, which bears US NIH Compound Identifier 3337. European Medicines Agency schedules Fenfluramine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02115MIG.

Most nations, for tariff and trade purposes, schedule fenfluramine hydrochloride under HS 29214980 and SITC 51454. As of Q4 2014, FENFLURAMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Fenfluramine hydrochloride bears US NLM identifiers UMLS ID C0282179 and NCI Concept Code C75112. SMILES: CCNC(C)CC1CCCC(C1)C(F)(F)F.CL.

UNSPSC 51144011 Fenfluramine hydrochloride is a Commodity code that nominally identifies a specific pharmaceutical active ingredient, but recent state and local procurement activity under this code shows minimal alignment with the code's stated scope. The three recent opportunities posted show state and local governments procuring naloxone and drug deactivation systems, therapeutic pharmacy initiatives with direct manufacturer relationships, and generic multi-source pharmaceuticals and OTC products through cooperative purchasing — none of which involve fenfluramine hydrochloride specifically. This mismatch suggests the code may be incorrectly tagged in the source jurisdictions' procurement systems, or the code is being used as a catch-all placeholder for pharmaceutical procurement rather than as a precise commodity identifier. State and local buyers appear to be using pharmaceutical codes inconsistently, which limits the utility of tracking fenfluramine hydrochloride procurement through this UNSPSC identifier.

Recent opportunities span Florida, Texas, and Minnesota-led cooperative purchasing. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 — a date inconsistency in the source data. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather vendor information about direct-to-manufacturer prescription programs, a preliminary market-research phase preceding formal procurement. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, posted RFP S1070000015802 in January 2026 seeking generic multi-source pharmaceuticals and OTC products for participating state and local facilities across multiple states including Oregon, with proposals due March 26, 2026. None of these opportunities target fenfluramine hydrochloride procurement, indicating the code currently shows little relevant recent activity for this specific pharmaceutical ingredient.